JOHN ANTHONY SALON
Pilots at Virginia Ter, Santa Paula, CA
License number
California A2647811
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
725 E Virginia Ter, Santa Paula, CA 93060
Professional information
Dna Encoding A Human Melanin Concentrating Hormone Receptor (Mch1) And Uses Thereof
US Patent:
6723552, Apr 20, 2004
Filed:
Jun 20, 2001
Appl. No.:
09/885478
Inventors:
John A. Salon - Santa Paula CA
Thomas M. Laz - Parlin NJ
Raisa Nagorny - Fair Lawn NJ
Amy E. Wilson - Woodstock NY
Thomas M. Laz - Parlin NJ
Raisa Nagorny - Fair Lawn NJ
Amy E. Wilson - Woodstock NY
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C12N 121
US Classification:
4352523, 4353201, 435348, 4352551, 435361, 435357, 435365, 435369, 435358, 435254, 536 235, 530350
Abstract:
This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors.
Methods Of Identifying Melanin Concentrating Hormone Receptor Antagonists
US Patent:
7393655, Jul 1, 2008
Filed:
Apr 15, 2004
Appl. No.:
10/825581
Inventors:
John A. Salon - Santa Paula CA, US
Thomas M. Laz - Parlin NJ, US
Raisa Nagorny - Fair Lawn NJ, US
Amy F. Wilson - Woodstock NY, US
Thomas M. Laz - Parlin NJ, US
Raisa Nagorny - Fair Lawn NJ, US
Amy F. Wilson - Woodstock NY, US
Assignee:
H. Lundbeck A/S - Valby-Copenhagen
International Classification:
G01N 33/53, C12N 15/00, C07K 14/00
US Classification:
435 721, 435 71, 435 72, 4352523, 4353201, 435361, 435336, 435357, 435365, 530350, 536 235
Abstract:
This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors.
Dna Encoding A Human Melanin Concentrating Hormone Receptor (Mch1) And Uses Thereof
US Patent:
2004003, Feb 26, 2004
Filed:
Jan 14, 2003
Appl. No.:
10/341751
Inventors:
John Salon - Santa Paula CA, US
Thomas Laz - Kennilworth NJ, US
Raisa Nagorny - Fair Lawn NJ, US
Amy Wilson - New York NY, US
Douglas Craig - Emerson NJ, US
Thomas Laz - Kennilworth NJ, US
Raisa Nagorny - Fair Lawn NJ, US
Amy Wilson - New York NY, US
Douglas Craig - Emerson NJ, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors. This invention further provides a method of treating a subject suffering from urinary incontinence which comprises administering to the subject an amount of an MCH1 antagonist effective to treat the subject's urinary incontinence.
Dna Encoding A Human Melanin Concentrating Hormone Receptor (Mch1) And Uses Thereof
US Patent:
2003007, Apr 24, 2003
Filed:
Dec 20, 2001
Appl. No.:
10/029314
Inventors:
Carlos Forray - Paramus NJ, US
John Salon - Santa Paula CA, US
Thomas Laz - Parlin NJ, US
Raisa Nagorny - Fairlawn NY, US
Amy Wilson - Woodstock NY, US
John Salon - Santa Paula CA, US
Thomas Laz - Parlin NJ, US
Raisa Nagorny - Fairlawn NY, US
Amy Wilson - Woodstock NY, US
International Classification:
C07K014/74, C07H021/04, C12P021/02, C12N005/06
US Classification:
435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors. This invention provides a method of modifying the feeding behavior of a subject which comprises administering to the subject an amount of an MCH1 antagonist effective to decrease the body mass of the subject and/or decrease the consumption of food by the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of an MCH1 antagonist effective to treat the subject's depression and/or anxiety.
Dna Encoding Edg7 Receptor
US Patent:
2003013, Jul 10, 2003
Filed:
Aug 26, 2002
Appl. No.:
10/228762
Inventors:
James Bonini - Oakland NJ, US
Ling Huang - Kearny NJ, US
Beth Borowsky - Flemington NJ, US
John Salon - Santa Paula CA, US
Amy Wilson - Woodstock NY, US
Raisa Nagorny - Fair Lawn NJ, US
Ling Huang - Kearny NJ, US
Beth Borowsky - Flemington NJ, US
John Salon - Santa Paula CA, US
Amy Wilson - Woodstock NY, US
Raisa Nagorny - Fair Lawn NJ, US
International Classification:
C07H021/04, C12Q001/68, C07K014/705, C12P021/02, C12N005/06, A61K038/17
US Classification:
536/023500, 530/350000, 514/012000, 435/006000, 435/069100, 435/320100, 435/325000
Abstract:
This invention provides isolated nucleic acids encoding mammalian Edg7 receptors, purified mammalian Edg7 receptors, vectors comprising nucleic acid encoding mammalian Edg7 receptors, cells comprising such vectors, antibodies directed to mammalian Edg7 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian Edg7 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian Edg7 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian Edg7 receptors, methods of isolating mammalian Edg7 receptors, methods of treating an abnormality that is linked to the activity of the mammalian Edg7 receptors, as well as methods of determining binding of compounds to mammalian Edg7 receptors, methods of identifying agonists and antagonists of Edg7 receptors, and agonists and antagonists so identified.